Performa HargaHarga kembali 1 minggu0.72%
Harga kembali 1 Bulan0.09%
Harga kembali 3 Bulan-1.09%
Harga kembali 6 Bulan10.47%
Harga Tertinggi (52 Minggu)78.46
Harga Terendah (52 Minggu)44.31
Latar Belakang Perusahaan
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
Summary
Valuation Information
Current PE Ratio (TTM)-11.35
Forward PE Ratio25
Current Price to Book Value2.96
Current Price to Sales379.43
EV to Revenue326.76
EV to EBITDA12.96
PEG Ratio-
Per Share
Current EPS (Annualized)-4.71
Diluted EPS (TTM)-4.71
Revenue Per Share0.14
Current Book Value Per Share18.07
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA-513174016
Profit Margin0
Operating Margin-11.28
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
Feed
Perfoma Harga
Statistik Utama
Berita
Broker Summary
Technical
Finansial
Laporan
Profil
Loading feeds...
